Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 2
2021 1
2022 3
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
The prostate tissue-based telomere biomarker as a prognostic tool for metastasis and death from prostate cancer after prostatectomy.
Heaphy CM, Joshu CE, Barber JR, Davis C, Lu J, Zarinshenas R, Giovannucci E, Mucci LA, Stampfer MJ, Han M, De Marzo AM, Lotan TL, Platz EA, Meeker AK. Heaphy CM, et al. Among authors: zarinshenas r. J Pathol Clin Res. 2022 Sep;8(5):481-491. doi: 10.1002/cjp2.288. Epub 2022 Jul 14. J Pathol Clin Res. 2022. PMID: 35836303 Free PMC article.
Racial Difference in Prostate Cancer Cell Telomere Lengths in Men with Higher Grade Prostate Cancer: A Clue to the Racial Disparity in Prostate Cancer Outcomes.
Heaphy CM, Joshu CE, Barber JR, Davis C, Zarinshenas R, De Marzo AM, Lotan TL, Sfanos KS, Meeker AK, Platz EA. Heaphy CM, et al. Among authors: zarinshenas r. Cancer Epidemiol Biomarkers Prev. 2020 Mar;29(3):676-680. doi: 10.1158/1055-9965.EPI-19-1462. Epub 2020 Jan 8. Cancer Epidemiol Biomarkers Prev. 2020. PMID: 31915143 Free PMC article.
Disease and toxicity outcomes for a modern cohort of patients with squamous cell carcinoma of cutaneous origin involving the parotid gland: Comparison of volumetric modulated arc therapy and pencil beam scanning proton therapy.
Zarinshenas R, Campbell P, Sun K, Molitoris JK, Patel AN, Witek ME, Cullen KJ, Mehra R, Hatten KM, Moyer KF, Taylor RJ, Vakharia KT, Wolf JS, Ferris MJ. Zarinshenas R, et al. Radiother Oncol. 2024 Apr;193:110112. doi: 10.1016/j.radonc.2024.110112. Epub 2024 Feb 1. Radiother Oncol. 2024. PMID: 38309587